Sections

• Preface
• Acknowledgments
• Contributors
• I. Clinical Demographics and Management
  • 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care
  • 2. Hepatocellular Carcinoma Surveillance and Staging
  • 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance
• II. Diagnosis and Prognostication
  • 4. Radiological Diagnosis and Characterization of HCC
  • 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery
  • 6. Molecular Subtypes and Genomic Signatures of Hepatocellular Carcinoma for Prognostication and Therapeutic Decision-Making
  • 7. Liquid Biopsy in Hepatocellular Carcinoma
• III. Treatment
  • 8. Surgical Therapies in Hepatocellular Carcinoma
  • 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began to Where We Are Going
  • 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy
  • 11. Molecular-Targeted Therapies in Hepatocellular Carcinoma
  • 12. Immune Therapies
  • 13. Prevention Strategies for Hepatocellular Carcinoma
• IV. Molecular Pathogenesis and Therapeutic Discovery
  • 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma
  • 15. Stromal and Immune Drivers of Hepatocarcinogenesis
  • 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma